Follow Us On
Powder
Files
Valganciclovir for Oral Solution
Strength: 50mg/mL
Count: 100mL
NDC
42291-972-01
Class
Rx
Brand Name
Valcyte
Imprint Code
NA
Color(s)
NA
Shape
NA
Score
NA
Case Count
NA
Inactive Ingredients
mannitol, sodium benzoate, sucralose, tartaric acid and tutti-frutti flavoring
Indications and Usage
1.2 Pediatric Patients Prevention of CMV Disease: Valganciclovir is indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk
